Emerging Biomarkers in the Laboratory and in Practice: A Novel Approach to Diagnosing Heart Failure in Diabetes
Study context
- Population
- People with T1D and T2D at risk of HF
- Outcome
- Topics reviewed
Methodological detailsHosted by Diabetes Technology Society on September 20, 2023, to review current evidence and management practices of biomarker screening for HF in people with diabetes
- Hosted by Diabetes Technology Society on September 20, 2023, to review current evidence and management practices of biomarker screening for HF in people with diabetes
Main finding
As reported in the abstract
- Four stages of HF
- Diabetes and HF
- Natriuretic peptide and troponin for diagnosing HF in diabetes
- Emerging composite and investigational biomarkers for diagnosing HF
- Prevention of HF progression
- Experts from clinical chemistry, cardiology and diabetology presented data on the importance of screening for HF as an often-unnoticed complication of T1D and T2D
Original publication
Emerging Biomarkers in the Laboratory and in Practice: A Novel Approach to Diagnosing Heart Failure in Diabetes. J Diabetes Sci Technol. Published 31 January 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →